Target intelligence / Profile preview

Corneal stromal stem cell (CSSC)

Target
CSSC
Molecular classification
Other
01

Overview

Corneal stromal stem cells (CSSCs) are adult stem cells located in the connective tissue of the corneal stroma. They exhibit multipotency, capable of differentiating into several cell types including keratocytes—the primary cells responsible for maintaining corneal structure and transparency. CSSCs express characteristic surface markers and stem cell genes, display high colony-forming efficiency, and their secretome (including exosomes) plays a major role in wound healing and anti-fibrotic activity. CSSCs are investigated as a therapeutic target for regenerating corneal tissue lost to injury, scarring, or degenerative disease, offering both cell-based (cell transplantation) and cell-free (exosome therapy) approaches. While promising, therapeutic use faces challenges such as tissue availability, product standardization, immune responses, and the need for robust clinical data.

Other names
Corneal stromal stem cellCSSCcorneal stem cell (generic; less specific)stromal stem cell (generic; less specific)
02

Mechanism of action

Direct tissue regeneration after transplantation. Paracrine activity: secretion of exosomes and cytokines (including microRNAs) that modulate local cell function, reduce fibrosis, and stimulate tissue repair. Differentiation into keratocytes to repopulate the stroma.

03

Biological functions

Tissue regenerationCell differentiation (into keratocytes, adipocytes, neural cells, osteocytes)Maintenance of corneal transparencyECM remodelingWound healingAnti-fibrotic activity through secretome/exosome-mediated modulation of fibroblasts
04

Disease associations

Corneal scarringVisual impairment or blindness due to stromal loss or fibrosisOther corneal injuries or degenerative diseases
05

Safety considerations

Donor tissue availability and standardization of cell productsRisk of immune rejection of transplanted cellsUnknown long-term integration and survival in host tissueManufacturing and regulatory quality for cell therapies
06

Interacting drugs

None established (CSSC-based therapies are cell or exosome-based interventions, not standard small molecule drugs)
07

Biomarkers

CD90CD73CD105STRO1CD166OCT4KLF4ABCG2keratocanlumicancollagen VCD34ALDH3A1 (for mature keratocytes)

Beyond the preview

Go deeper on Corneal stromal stem cell (CSSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal stromal stem cell (CSSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call